Evaluation of suspected malignancies: Difference between revisions

Jump to navigation Jump to search
Mikael Häggström (talk | contribs)
Mikael Häggström (talk | contribs)
+Additional slices
Line 28: Line 28:
===Typing and grading===
===Typing and grading===
Beyond determining overall malignancy, probable origin and staging, classification of tumors into a specific histopathologic type or grade is of relatively less value. In cases of clearly non-malignant tumors where it is difficult to determine the specific histopathologic type or grade, it is generally acceptable to conclude the evaluation and report it as such, unless the clinician specifically requests otherwise. For potentially malignant or high-risk tumors, typing and grading often still affects the management.
Beyond determining overall malignancy, probable origin and staging, classification of tumors into a specific histopathologic type or grade is of relatively less value. In cases of clearly non-malignant tumors where it is difficult to determine the specific histopathologic type or grade, it is generally acceptable to conclude the evaluation and report it as such, unless the clinician specifically requests otherwise. For potentially malignant or high-risk tumors, typing and grading often still affects the management.
==Additional slices==
*Additional slices are indicated for example in cases where re-excision does not identify tumor cells in a clearly non-radical primary excision or biopsy.<ref group="notes">In such cases, step slices are taken rather than serial ones.</ref>
{{Bottom}}
{{Bottom}}